XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
Net Sales
 9 Months Ended
Sep. 30, 2022
Revenue From Contract With Customer [Abstract]  
Net Sales

8. Net Sales

Disaggregated Net Sales

We primarily derive our revenues from the sales of various chemical products. The Company’s net sales disaggregation is consistent with other financial information utilized or provided outside of our condensed consolidated financial statements. With our continued focus on optimizing our commercial strategy and product mix going forward we will report revenue by product as opposed to the end market. Accordingly, this approach is reflected in disaggregated net sales, mirroring how the Company manages its net sales by product through contracts with customers.

The following table presents our net sales disaggregated by our principal product types:

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

 

 

(In Thousands)

 

Net sales:

 

 

 

 

 

 

 

 

 

 

 

 

AN & Nitric Acid

 

$

66,161

 

 

$

47,453

 

 

$

234,103

 

 

$

154,029

 

Urea ammonium nitrate (UAN)

 

 

50,459

 

 

 

26,034

 

 

 

184,014

 

 

 

73,571

 

Ammonia

 

 

52,075

 

 

 

42,307

 

 

 

200,861

 

 

 

102,013

 

Other

 

 

15,578

 

 

 

11,405

 

 

 

49,079

 

 

 

36,398

 

Total net sales

 

$

184,273

 

 

$

127,199

 

 

$

668,057

 

 

$

366,011

 

Other Information

Although most of our contracts have an original expected duration of one year or less, for our contracts with a duration greater than one year at contract inception, the average remaining expected duration was approximately 21 months at September 30, 2022.

Liabilities associated with contracts with customers (contract liabilities) primarily relate to deferred revenue and customer deposits associated with cash payments received in advance from customers for volume shortfall charges and product shipments. We had approximately $1.1 million and $1.6 million of contract liabilities as of September 30, 2022 and December 31, 2021, respectively. For the three and nine months ended September 30, 2022, revenues of $0.2 million and $1.5 million, respectively, were recognized and included in the balance at the beginning of the respective period. For the three and nine months ended September 30, 2021, revenues of $0.6 million and $2.2 million, respectively, were recognized and included in the balance at the beginning of the respective period.

For most of our contracts with customers, the transaction price from the inception of a contract is constrained to a short period of time (generally one month) as these contracts contain terms with variable consideration related to both price and quantity. At September 30, 2022, we have remaining performance obligations with certain customer contracts, excluding contracts with original durations of less than one year and for service contracts for which we have elected the practical expedient for consideration recognized in revenue as invoiced. The remaining performance obligations totals approximately $69 million, of which approximately 33% of this amount relates to 2022 through 2024, approximately 33% relates to 2025 through 2026, with the remainder thereafter.